[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368419-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-368419-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","cannabidiol-as-a-novel-therapeutic-agent-in-breast-cancer-evidence-from-literature","Cannabidiol as a Novel Therapeutic Agent in Breast Cancer - Evidence from Literature","","Background Breast cancer is one of the most prevalent cancers worldwide, presenting major obstacles due to tumor heterogeneity and the emergence of drug resistance. Cannabidiol (CBD), a non-psychoactive compound from Cannabis sativa, has attracted attention for potential therapeutic effects. Objective This review evaluates CBD’s antitumor effects in breast cancer. Methods A systematic review followed PRISMA, searching PubMed, Google Scholar, Web of Science, and Scopus. Results CBD showed anti-cancer activity through apoptosis induction, proliferation inhibition, metastasis suppression, and tumor microenvironment modulation, involving pathways such as PI3K/Akt, mTOR, and PPARγ. Conclusion CBD is promising, though clinical translation remains limited by heterogeneity and the lack of standardized protocols.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cannabidiol-as-a-novel-therapeutic-agent-in-breast-cancer-evidence-from-literature/368419/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cannabidiol-as-a-novel-therapeutic-agent-in-breast-cancer-evidence-from-literature/368419.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of this literature review?","Question",{"text":63,"@type":64},"To evaluate the antitumor effects of cannabidiol (CBD) in breast cancer by synthesizing preclinical and clinical evidence, clarifying mechanisms of action, and discussing translational potential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the review conducted?",{"text":68,"@type":64},"It used a systematic review approach following PRISMA guidelines, searching PubMed, Google Scholar, Web of Science, and Scopus and selecting studies published from 1998 to 2025 after eligibility screening.",{"name":70,"@type":61,"acceptedAnswer":71},"What anticancer effects does CBD show in breast cancer studies?",{"text":72,"@type":64},"CBD is reported to induce apoptosis, inhibit cell proliferation, suppress metastasis, and modulate the tumor microenvironment, including pathway regulation such as PI3K/Akt, mTOR, and PPARγ.",{"name":74,"@type":61,"acceptedAnswer":75},"What challenges limit CBD’s clinical application in breast cancer?",{"text":76,"@type":64},"Variability in study design, lack of standardized protocols, and limited clinical validation hinder reliable clinical integration, requiring more robust trials and biomarker-driven approaches.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},368419,1790219384,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":121,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":108,"preview_page_count":33,"preview_urls":148},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Esmaeli etal. BMC Cancer (2025) 25:772 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14175-z](https://doi.org/10.1186/s12885-025-14175-z)  \nRESEARCH Open Access  \nCannabidiol as a novel therapeutic agent in breast cancer: evidence from literature  \nMojtaba Esmaeli 1*, Maryam Dehghanpour Dehabadi 1 and Ali Asghar Khaleghi2  \nAbstract  \nBackground Breast cancer is one of the most prevalent cancers worldwide, posing significant challenges due to its heterogeneity and the emergence of drug resistance. Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has recently gained attention for its potential therapeutic effects in breast cancer.  \nObjective This review aims to evaluate the antitumor effects of CBD in breast cancer treatment by synthesizing preclinical and clinical evidence, elucidating its mechanisms of action, and exploring its translational potential. Methods A systematic review was conducted following PRISMA guidelines. A comprehensive search was performed across PubMed, Google Scholar, Web of Science, and Scopus databases, using keywords such as“Cannabidiol,”“CBD,”“Breast Cancer,”“Therapeutic Agent,” and “Antitumor Effects.” A total of 1,191 articles were initially identified. After duplicate removal and eligibility screening, 34 studies published between 1998 and 2025 were selected, including in vitro, in vivo, and clinical investigations. Studies were assessed based on PRISMA recommendations, considering inclusion criteria such as CBD’s impact on apoptosis, cell proliferation, tumor progression, and molecular mechanisms. Results CBD demonstrated significant anticancer effects, including induction of apoptosis, inhibition of cell proliferation, suppression of metastasis, and modulation of the tumor microenvironment. Mechanistically, CBD modulates key pathways such as PI3K/Akt, mTOR, and PPARγ and interacts with CB1, CB2, and non-cannabinoid receptors. Preclinical studies showed CBD’s efficacy, particularly in triple-negative breast cancer (TNBC), while limited clinical trials highlighted its potential as an adjunct to conventional therapies.  \nConclusion CBD offers a promising therapeutic approach for breast cancer, especially for aggressive subtypes like TNBC. However, challenges such as variability in study design, lack of standardized protocols, and limited clinical validation hinder its clinical application. Future research should focus on conducting robust clinical trials, identifying predictive biomarkers, and optimizing combinatorial therapies to integrate CBD into personalized cancer treatment strategies.  \nKeywords Cannabidiol (CBD), Breast cancer, Triple-negative breast cancer (TNBC), Apoptosis, Metastasis, Molecular pathways, Clinical translation  \n*Correspondence:  \nMojtaba Esmaeli  \n[dr.esmaeli1987@gmail.com](dr.esmaeli1987@gmail.com)  \n1Cellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran  \n2Department of Medical Emergencies, School of Medicine, Fasa University of Medical Science, Fasa, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nEsmaeli et al. BMC Cancer (2025) 25:772  \nIntroduction  ","cbCaiqR27w4WYFBV","https://ap.wps.com/l/cbCaiqR27w4WYFBV","pdf",2834953,"English","# Abstract\n# Introduction\n## Background and rationale\n## CBD mechanisms and evidence\n## Preclinical and clinical context\n# Conclusion and future directions","[{\"question\":\"What is the main purpose of this literature review?\",\"answer\":\"To evaluate the antitumor effects of cannabidiol (CBD) in breast cancer by synthesizing preclinical and clinical evidence, clarifying mechanisms of action, and discussing translational potential.\"},{\"question\":\"How was the review conducted?\",\"answer\":\"It used a systematic review approach following PRISMA guidelines, searching PubMed, Google Scholar, Web of Science, and Scopus and selecting studies published from 1998 to 2025 after eligibility screening.\"},{\"question\":\"What anticancer effects does CBD show in breast cancer studies?\",\"answer\":\"CBD is reported to induce apoptosis, inhibit cell proliferation, suppress metastasis, and modulate the tumor microenvironment, including pathway regulation such as PI3K/Akt, mTOR, and PPARγ.\"},{\"question\":\"What challenges limit CBD’s clinical application in breast cancer?\",\"answer\":\"Variability in study design, lack of standardized protocols, and limited clinical validation hinder reliable clinical integration, requiring more robust trials and biomarker-driven approaches.\"}]","Cannabidiol as a Novel Therapeutic Agent in Breast Cancer - Evidence from Literature | PDF",1790176866,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3c4f26ebfe579245567163ad3b93c80.webp",983,1310,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1030a4691866df842b2e605cb3eb6a16.webp",982,1309,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60888b45560ac7fb4adb2f07f4ec0dc9.webp",981,1308,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8230b5e9f0c3416ba625046697408772.webp",980,1306]